docetaxel

Intravenous Versus Oral Dexamethasone Premedication in Preventing Paclitaxel Infusion Hypersensitivity Reactions in Gynecological Malignancies
Sean M. O’Cathail, Roekshana Shaboodien, Sarah Mahmoud, Karen Carty, Patrick O’Sullivan, Sarah Blagden, Hani Gabra, Sue Whear, Janice S. Kwon, Roshan Agarwal

International Journal of Gynecologic Cancer Sep 2013, 23 (7) 1318-1325; DOI: 10.1097/IGC.0b013e31829f1799
Phase II Study of Docetaxel Weekly in Combination With Carboplatin Every 3 Weeks as First-Line Chemotherapy in Stage IIB to Stage IV Epithelial Ovarian Cancer
Bengt Sorbe, Marianne Graflund, György Horvath, Marie Swahn, Karin Boman, René Bangshöj, Margareta Lood, Henric Malmström

International Journal of Gynecologic Cancer Jan 2012, 22 (1) 47-53; DOI: 10.1097/IGC.0b013e318234fa3a
Phase II Study of Combination Chemotherapy With Docetaxel and Carboplatin for Locally Advanced or Recurrent Cervical Cancer
Shigeki Takekida, Keiichi Fujiwara, Shoji Nagao, Satoshi Yamaguchi, Nobutaka Yoshida, Fuminori Kitada, Junzo Kigawa, Naoki Terakawa, Ryuichiro Nishimura

International Journal of Gynecologic Cancer Nov 2010, 20 (9) 1563-1568; DOI: 10.1111/IGC.0b013e3181a81221
Docetaxel in combination with carboplatin for chemo-naive patients with epithelial ovarian cancer
Y. Aoki, T. Sato, I. Tsuneki, M. Watanabe, H. Kase, K. Fujita, H. Kurata, K. Tanaka

International Journal of Gynecologic Cancer Oct 2002, 12 (6) 704-709; DOI: 10.1136/ijgc-00009577-200211000-00003
Discordance of clinical symptoms and electrophysiologic findings in taxane plus platinum-induced neuropathy
Y. Pan, M.-S. Kao

International Journal of Gynecologic Cancer Feb 2007, 17 (2) 394-397; DOI: 10.1111/j.1525-1438.2006.00766.x
High Efficacy and Low Toxicity of the Modified Docetaxel and Carboplatin Protocol in Patients with Recurrent Ovarian Cancer—A Phase 2 Cohort Study
Ilan Bruchim, Natalie Weeg, Yoav Alpert, Dana Sade, Ettie Piura, Ami Fishman

International Journal of Gynecologic Cancer May 2016, 26 (4) 640-647; DOI: 10.1097/IGC.0000000000000666
Phase 2 Trial of Docetaxel, Gemcitabine, and Oxaliplatin Combination Chemotherapy in Platinum- and Paclitaxel-Pretreated Epithelial Ovarian Cancer
Gregor Seliger, Lutz P. Mueller, Thomas Kegel, Eva J. Kantelhardt, Axel Grothey, Regina GroßE, Hans-Georg Strauss, Heinz Koelbl, Christoph Thomssen, Hans-Joachim Schmoll

International Journal of Gynecologic Cancer Nov 2009, 19 (8) 1446-1453; DOI: 10.1111/IGC.0b013e3181b62f38
Outpatient Platinum-Taxane Intraperitoneal Chemotherapy Regimen for Ovarian Cancer
Leigh G. Seamon, Matthew J. Carlson, Debra L. Richardson, David E. Cohn, Jeffrey M. Fowler, Larry J. Copeland, David M. O'Malley

International Journal of Gynecologic Cancer Oct 2009, 19 (7) 1195-1198; DOI: 10.1111/IGC.0b013e3181b33d5b
Recurrent small cell carcinoma of the ovary treated with docetaxel: a case report
S. Niimi, T. Kiyokawa, S. Takakura, K. Ochiai, T. Tanaka

International Journal of Gynecologic Cancer Sep 2006, 16 (5) 1944-1946; DOI: 10.1136/ijgc-00009577-200609000-00035
Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy
D. A. VOROBIOF, B.L. RAPOPORT, M. R. CHASEN, G.L. COHEN, R. MAHOMED, M. KARIME

International Journal of Gynecologic Cancer May 2003, 13 (3) 287-291; DOI: 10.1136/ijgc-00009577-200305000-00004

Main menu

docetaxel

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

docetaxel

Pages